Across TCGA pan-cancer cohorts, LINC00639 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated LINC00639 data layer compared with 22 for mass-spec protein.
The strongest signal is observed in lung adenocarcinoma (LUAD), where higher LINC00639 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated LINC00639 expression acts as an unfavorable survival marker.
LUAD are the cancer types where LINC00639 Mutation most reproducibly stratifies survival.